Oral ensartinib is effective in patients with co-existing ALK fusion and point mutations

Saved in:
Bibliographic Details
Published inAsian journal of surgery Vol. 46; no. 9; pp. 4088 - 4089
Main Authors Yao, Zhijian, Li, Xin, An, Xiyu, Cui, Dongyu
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.09.2023
Elsevier
Online AccessGet full text

Cover

More Information
ISSN:1015-9584
DOI:10.1016/j.asjsur.2023.04.068